Vaccine Trials Equipment & Supplies
10 equipment items found
Manufactured by:Maxim Biomedical based inRockville, MARYLAND (USA)
The Maxim Swift HIV Recent Infection Assay (RIA) Kit Controls are quality control reagents for use only with the Maxim Swift™ HIV Recent Infection Assay (RIA) (P/N 92002). They are used to verify that the test kit reagents are working and that the test is performed correctly. The Maxim Swift™ HIV RIA uses US CDC developed materials and is designed for surveillance purposes such as ...
Manufactured by:Maxim Biomedical based inRockville, MARYLAND (USA)
The Maxim HIV-1 Limiting Antigen-Avidity EIA is an in-vitro quantitative limiting antigen (LAg) avidity enzyme immunoassay for distinguishing recent HIV-1 infections from those which are long-term. Persons with recently acquired HIV-1 infections typically exhibit HIV-1 specific IgG populations with higher proportions of lower avidity IgG than those with long-term infections which typically ...
Manufactured by:Maxim Biomedical based inRockville, MARYLAND (USA)
The Maxim HIV-1 Limiting Antigen-Avidity Dried Blood Spot (DBS) EIA is an in-vitro quantitative limiting antigen (LAg) avidity enzyme immunoassay for distinguishing recent HIV-1 infections from those which are long-term. Persons with recently acquired HIV-1 infections typically exhibit HIV-1 specific IgG populations with higher proportions of lower avidity IgG than those with long-term infections ...
Manufactured by:Maxim Biomedical based inRockville, MARYLAND (USA)
The Maxim Swift HIV Recent Infection Assay (RIA) is a single use qualitative immunoassay to detect the circulating antibodies to Human Immunodeficiency Virus Type 1 (HIV-1), Type 2 (HIV-2) and distinguish between recent and long-term infection in HIV-1/2. The assay is a point of care (POC) test intended for use with blood or serum/ plasma specimens. The Maxim Swift™ HIV RIA uses US CDC ...
Manufactured by:ORYX GmbH & Co. KG based inBaldham, GERMANY
The human cyclin-dependent kinase inhibitor p16INK4a is a tumor antigen expressed in various cancers, including lung and breast cancer. In normal cells, p16INK4a is rarely expressed and leads to immediate senescence. In all cancers associated with high risk human papilloma virus (HR-HPV), p16INK4a is constantly expressed as an early consequence of HR-HPV-mediated cell transformation. About 5% of ...
Manufactured by:Sedia Biosciences Corporation based inBeaverton, OREGON (USA)
An in vitro single well quantitative limiting antigen avidity enzyme immunoassay for distinguishing recent HIV-1 infections from those which are long-term. Intended for use with liquid serum or plasma specimens. ...
Manufactured by:Dixion distribution of medical devices GmbH based inDüsseldorf, GERMANY
The kit is used to detect the neutralizing antibody to SARS-CoV-2 in human serum, plasma or whole blood sample quantitatively. It is mainly used to identify individuals with acquired immune response to the SARS-CoV-2, and to evaluate the effectiveness of the vaccine clinical trials and mass ...
Manufactured by:Altimmune Inc. based inGaithersburg, MARYLAND (USA)
Identical vector technology used for AdCOVID (COVID-19), NasoVAX (seasonal influenza) and NasoShield (anthrax) ...
Manufactured by:Treos Bio Limited based inLondon, UNITED KINGDOM
At TREOS we use knowledgebase and algorithm embedded in PASCal (Personal Antigen Selection Calculator) tool to develop personal cancer immunotherapies. PASCal supports the development of immunotherapies for single individuals and a population of individuals with a specific genetic background, including specific peptides most effective in ethnic ...
Manufactured by:Treos Bio Limited based inLondon, UNITED KINGDOM
Using our proprietary computational vaccine design technology, we have developed a PolyPEPI preventive peptide vaccine against COVID-19 (SARS-CoV-2). The design of PolyPEPI-SCoV-2 exploits our knowledge on genetic heterogeneity of individuals and ethnicities. PolyPEPI-SCoV-2 vaccine can elicit broad and long-lasting immune responses in vaccinated subjects and can therefore protect people ...
